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Experimental Section 
 
1.  Chemicals and Reagents 
 
All manipulations were carried out under an inert N2(g) atmosphere using standard Schlenk 
or glovebox techniques. Solvents were purified using a two-column solid-state purification 
system (Innovative Technology, NJ, USA) and transferred to the glove box without exposure 
to air. Deuterated solvents were purchased from Cambridge Isotope Laboratories, Inc., and 
were degassed and stored over activated 3 Å molecular sieves. THF-d8 was purchased from 
ARMAR AG, and was degassed and stored over activated 3 Å molecular sieves. Unless 
otherwise noted, all other reagents and starting materials were purchased from commercial 
sources and used without further purification. Liquid compounds were degassed by standard 
freeze-pump-thaw procedures prior to use. Tetrahydropyran and 2-methyltetrahydrofuran 
were distilled from stabilizers before use. Dry 1,2-dimethoxyethane was purchased from 
Aldrich and used without purification. Diphenyl iodonium hexafluorophosphate and triflate 
were purchased from ABCR and Aldrich correspondently. 2,2-Dimethylpent-4-en-1-amine 
was synthesized according to literature procedure.
1
 Other amines were purchased from 
commercial sources. Sulfonamides
2
, amides and trifluoroacetyl amides
3
 were prepared from 
corresponding amines by standard methods. 3-(4-methoxybenzyl)-5-methylpyrimidine-
2,4(1H,3H)-dione
4
 and di-tert-butyl 5-fluoro-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate
5
 
were prepared according to known procedures. 
 
2.  Physical methods 
 
The 
1
H and 
13
C NMR spectra were recorded at 293 K or 373 K on Bruker Avance 400 
spectrometers. 
1
H NMR chemical shifts were referenced to residual solvent as determined 
relative to Me4Si (δ = 0 ppm). The 
13
C{
1
H} chemical shifts were reported in ppm relative to 
the carbon resonance of CDCl3 (77.16 ppm), DMSO-d6 (39.52 ppm), CD2Cl2 (53.84 ppm) or 
CD3CN (118.26 ppm). GC measurement was conducted on a Perkin-Elmer Clarus 400 GC 
with a FID detector. HRESI-MS measurements were conducted at the EPFL ISIC Mass 
Spectrometry Service with a Micro Mass QTOF Elemental analyses were performed on a 
Carlo Erba EA 1110 CHN instrument at EPFL.  
 
3. General procedures for the entries reported in Table 1 
Entries 1-10, 18-20 
Sodium hydride (60% dispersion in mineral oil, 10 mg, 0.25 mmol, entries 1-7) or 
corresponding base (0.25 mmol, entries 8-10) was added to a stirred solution of N-
benzylmethanesulfonamide (46 mg, 0.25 mmol) in 1 mL of dry tetrahydrofuran at room 
temperature under nitrogen. After stirring for 1 hour an oxidant (0.3 mmol) was added slowly 
and the reaction mixture was left stirred for 10 hours. In entry 5 no oxidant was added; 
instead a balloon with O2 was connected to reaction vessel. After the indicated time, the 
reaction mixture was analyzed by GCMS using 30 μL of dodecane as an internal standard.  
Entries 11-17  
Sodium hydride (60% dispersion in mineral oil, 10 mg, 0.25 mmol) was added to a stirred 
solution of N-benzylmethanesulfonamide (46 mg, 0.25 mmol) and dry tetrahydrofuran (0.18 
g, 2.5 mmol) in 1 mL of the corresponding solvent at room temperature under nitrogen. After 
stirring for 1 hour Ph2IPF6 (128 mg, 0.3 mmol) was added and the reaction mixture was left 
stirred for 10 hours. 
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4. The procedures for the preparation of starting materials 
General procedure for the preparation of sulfonamides (1a-1m) 
To a stirred solution of primary amine (20 mmol) and pyridine (2.37 g, 30 mmol) in CH2Cl2 
(50 mL) at 0° C a corresponding sulfonyl chloride (20 mmol) was slowly added. The reaction 
mixture was slowly warmed to room temperature and stirred for 12 hours, then the reaction 
was quenched with water (30 mL), extracted with CH2Cl2 (2x50 mL) and washed with water. 
The organic phase was dried over anhydrous Na2SO4. The solvent was evaporated to afford 
the product. If needed, crude product was purified by silica gel flash chromatography using 
mixture of ethylacetate/hexane as an eluent.  
 
General procedure for the preparation of N-acetamides (2a-2d, 2i-2o) 
20 mmol of the corresponding amine was dissolved in 50 mL of CH2Cl2 followed by the 
addition of triethylamine (3.03 g, 30 mmol) and dropwise addition of acetyl chloride (1.72 g, 
22 mmol) at 0° C. After stirring for 10 hours at room temperature 30 mL of water was added 
to the reaction solution. The organic phase was separated and aqueous layer was extracted 
two times with 50 mL of chloroform, and the resulting organic layer was concentrated after 
drying with anhydrous Na2SO4 to obtain the product. If needed, crude product was purified 
by silica gel flash chromatography using mixture of ethylacetate/hexane as an eluent. 
 
General procedure for the preparation of N-trifluoroacetamides (2e-2h)  
20 mmol of the corresponding amine and pyridine (2.37 g, 30 mmol) were dissolved in 50 
mL of dry CH2Cl2. Trifluoracetic anhydride (22 mmol 4.62 g) in 20 mL of CH2Cl2 was added 
slowly at 0ºC. The reaction was stirred overnight at room temperature, quenched with water, 
extracted twice with CH2Cl2 and washed with water. The organic layers were dried with 
Na2SO4, and the solvent was evaporated. The residue was purified by silica gel flash 
chromatography using mixture of hexane/ethyl acetate as an eluent.  
 
 
Tert-butyl 5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate (9b) 
 
 
5-Fluorouracil (3.9 g, 30.0 mmol), di-tert-butyl dicarbonate (26.2 g, 120 mmol), pyridine (5 
mL), DMAP (100 mg, 0.8 mmol) and MeCN (50 mL) were stirred together for 12 h at room 
temperature. The reaction mixture was concentrated in vacuo, and the residue was partitioned 
between CH2Cl2 (100 mL) and water (100 mL). The organic layer was separated, and the 
aqueous phase was extracted twice with CH2Cl2 (2×50 mL). The combined organic layers 
were dried over MgSO4 and filtered, and the solvent was removed by evaporation in vacuo. 
The residue was purified by recrystallization from Hexane-EtOAc (10:1) to afford 6.70 g 
(68%) of di-tert-butyl 5-fluoro-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate (9b’). 
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Purified 9b’ (330 mg, 1 mmol) was dissolved under argon in 2 mL of dry THF. A 1 M 
solution of Bu4NF (1.5 mL, 1.5 mmol) in THF was then added and the reaction mixture was 
refluxed for 8 h. After cooling to room temperature, water (20 mL) was added. After 
extraction with AcOEt (2×20 mL), the organic layers were washed with brine (10 mL), dried 
with Na2SO4, filtered and the solvent was removed under reduced pressure. The crude 
product was purified by gradient silica gel chromatography (hexane/AcOEt 10:1 to 1:1) to 
afford N3-Boc-5-fluorouracil as white powder 87 mg (38%). 
 
5. General procedures for the intermolecular α-C-H amination of ethers 
General procedure for the synthesis of N-(tetrahydrofuran-2-yl)sulfonamides (3a-3n) 
To a suspension of sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) in 1 mL 
of dry THF a sulfonamide (0.5 mmol) in 1 mL of THF was added at room temperature under 
nitrogen. After stirring for 1 hour at room temperature Ph2IPF6 (256 mg, 0.6 mmol) was 
added and the reaction mixture was left stirred for 6 hours. The solvent was removed under 
reduced pressure and resulting solid was subjected to column chromatography (silica gel) to 
afford the product. For the new compounds, their 
1
H and 
13
C data were reported together with 
high resolution mass spectrometric data or elemental analysis. 
 
General procedure for the synthesis of N-(tetrahydrofuran-2-yl)amides (5a-5o) 
To a suspension of sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) in 1 mL 
of dry THF an amide (0.5 mmol) in 1 mL of THF was added at room temperature under 
nitrogen. After stirring for 3 hours at room temperature Ph2IPF6 (319 mg, 0.75 mmol) in 1 
mL of THF was added and the reaction mixture was left stirred for 6 hours. The solvent was 
removed under reduced pressure and resulting solid was subjected to the column 
chromatography (silica gel) to afford the product. For the new compounds, their 
1
H and 
13
C 
data were reported together with high resolution mass spectrometric data or elemental 
analysis. 
 
General procedure for the synthesis of phthalimide derivatives (5p, 8b, 8d) 
To a suspension of potassium phthalimide (92.5 mg, 0.5 mmol) in 2 mL of corresponding 
alkyl ether Ph2IPF6 (256 mg, 0.6 mmol) was added and reaction mixture stirred at 40˚C or 
60˚C overnight under nitrogen. The solvent was removed under reduced pressure and 
resulting solid was subjected to the column chromatography (silica gel) to afford the product. 
 
General procedure for the α-C-H bond amination with N-heterocyclic amines (7a-7d) 
To a suspension of sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) in 1 mL 
of dry THF an amine (0.5 mmol) in 1 mL of THF was added at room temperature under 
nitrogen. After stirring for 1 hour at room temperature Ph2IPF6 (319 mg, 0.75 mmol) was 
added and the reaction mixture was left stirred for 6 hours. The solvent was removed under 
reduced pressure and resulting solid was subjected to column chromatography (silica gel) to 
afford the product. For the new compounds, their 
1
H and 
13
C data were reported together with 
high resolution mass spectrometric data or elemental analysis. 
 
General procedure for the α-C-H bond amination of various alkyl ethers (8a-8h) 
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To a suspension of sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) in 3 mL 
of dry alkyl ether an amide or sulfonamide (0.5 mmol) was added at room temperature under 
nitrogen. After stirring for 3 hours at room temperature Ph2IPF6 (319 mg, 0.75 mmol) was 
added and the reaction mixture was left stirred for 6 hours. The solvent was removed under 
reduced pressure and resulting solid was subjected to the column chromatography (silica gel) 
to afford the product. For the new compounds, their 
1
H and 
13
C data were reported together 
with high resolution mass spectrometric data or elemental analysis. 
 
General procedure for the synthesis of nucleoside analogues (10a-10d) 
To a suspension of sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) in 1 mL 
of dry alkyl ether and N3-protected nucleobase (0.5 mmol) was added at room temperature 
under nitrogen. After stirring for 3 hours at room temperature Ph2IPF6 (362 mg, 0.85 mmol) 
in 2 mL of ether was added and the reaction mixture was left stirred for 6 hours. The solvent 
was removed under reduced pressure and resulting solid was subjected to the column 
chromatography (silica gel) to afford the product. For the new compounds, their 
1
H and 
13
C 
data were reported together with high resolution mass spectrometric data or elemental 
analysis. 
 
6. Mechanistic studies 
Reaction in the presence of TEMPO 
Sodium hydride (60% dispersion in mineral oil, 20 mg, 0.5 mmol) was added to a stirred 
solution of N-benzylmethanesulfonamide (93 mg, 0.5 mmol) in 1 mL of dry tetrahydrofuran 
at room temperature under nitrogen. After stirring for 1 hour TEMPO (7.8 mg, 0.05mmol) 
and Ph2IPF6 (256 mg, 0.6 mmol) was added, and the reaction mixture was left stirred for 6 
hours. After the indicated time the reaction mixture was analyzed by GCMS using 30 μL of 
dodecane as an internal standard. 3a was not detected. 
 
Comparison of rate constants of the reactions of acetanilide (4d) with THF and THF-d8 
Four stock solutions were prepared: 405 mg of acetanilide and 102 mg of dodecane  in 6.0 
mL of THF (Solution A); 1.50 g of Ph2IPF6 in 5.0 mL of THF (Solution B); 405 mg of 
acetanilide and 102 mg of dodecane in 6.0 mL of THF-d8 (Solution C); 1.50 g of Ph2IPF6 in 
5.0 mL of THF-d8 (Solution D). To 1.0 mL of Solution A 20 mg of sodium hydride (60% 
dispersion in mineral oil) was added and the mixture was stirred for 30 minutes. Then 1.0 mL 
of Solution B was added at once at room temperature (23,5 ˚C). The aliquotes of the reaction 
mixture were quenched with ethanol and analyzed by GC (calibration was performed using 
dodecane as an internal standard). The procedure was repeated with Solutions C and D. The 
ratio between both reaction rate constants was determined to be 4.60. 
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Figure S1. The rate of the reaction of acetanilide (4d) in THF 
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Figure S2. The rate of the reaction of acetanilide (4d) in THF-d8 
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7.  Detailed descriptions of the products 
 
N-benzyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3a) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 4:1) in 73% yield as 
a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.42 (d, J = 7.5 Hz, 2H), 7.37-7.34 (m, 2H), 7.30-7.26 (m, 1H), 
5.72 -5.69 (m, 1H), 4.57 (d, J = 16.7 Hz, 1H), 4.27 (d, J = 16.7 Hz, 1H), 4.07-4.01 (m, 1H), 
3.84-3.79 (m, 1H), 2.97 (s, 3H), 2.08-1.81 (m, 3H), 1.75-1.69 (m, 1H). 
13
C NMR (101 MHz, CDCl3): 138.3, 128.7, 127.5, 127.1, 88.8, 68.4, 46.6, 39.6, 29.6, 24.8. 
HRESI-MS: calculated for (C12H17NO3S, M+H), 256.1007; found, 256.1000. 
 
 
N-cyclohexyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3b) 
Isolated by gradient elution from the column with hexane-EtOAc (20:1 to 9:1) 76% yield as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3): 5.34 (m, 1H), 4.05-3.99 (m, 1H), 3.77-3.73 (m, 1H), 3.38-3.31 
(m, 1H), 2.98 (s, 3H), 2.19-2.02 (m, 3H), 1.92-1.60 (m, 8H), 1.34-1.08 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 88.7, 68.1, 57.5, 43.4, 34.2, 31.4, 31.0, 26.6, 25.3. 
HRESI-MS: calculated for (C11H21NO3S, M+Na), 270.1140; found, 270.1143. 
 
 
N-(tert-butyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (3c) 
Isolated by gradient elution from the column with hexane-EtOAc (19:1 to 9:1) in 39% yield 
as a white solid. 
1
H NMR (400 MHz, CD2Cl2): 5.33-5.29 (m, 1H), 4.08-4.03 (m, 1H), 3.74-3.69 (m, 1H), 2.99 
(s, 3H), 2.51-2.44 (m, 1H), 2.12-1.99 (m, 2H), 1.88-1.79 (m, 1H), 1.43 (s, 9H). 
13
C NMR (101 MHz, CD2Cl2): 90.6, 68.5, 59.7, 45.7, 32.9, 30.8, 25.8. 
HRESI-MS: calculated for (C9H19NO3S, M+Na), 244.0983; found, 244.0984. 
Elemental analysis: Anal. Calcd for C9H19NO3S: C, 48.84; H, 8.65; N 6.33. Found: C, 
48.88; H, 8.35; N 6.15. 
 
 
N-(2,2-dimethylpent-4-en-1-yl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (3d) 
Isolated by gradient elution from the column with hexane-EtOAc (6:1 to 4:1) in 78 % yield as 
colorless oil. 
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1
H NMR (400 MHz, CDCl3): 5.88-5.78 (m, 1H), 5.32-5.03 (m, 3H), 4.11-4.06 (m, 1H), 3.81-
3.76 (m, 1H), 3.24 (d, J = 14.7 Hz, 1H), 2.98 (s, 3H), 2.91 (d, J = 14.7 Hz, 1H), 2.54-2.45 (m, 
1H), 2.22-2.10 (m, 2H), 2.03 (m, 2H), 1.89-1.82 (m, 1H), 0.95 (s, 3H), 0.94 (s, 3H). 
13
C NMR (101 MHz, CDCl3): 134.8, 117.8, 94.7, 77.2, 68.6, 59.6, 45.4, 40.8, 35.5, 31.7, 
25.737, 25.3, 25.1. 
HRESI-MS: calculated for (C12H23NO3S, M+H), 262.1477; found 262.1472. 
 
 
N-allyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3e) 
Eluated from the column with hexane-EtOAc (9:1) in 77% yield as a colorless oil 
1
H NMR (400 MHz, CDCl3): 5.97-5.87 (m, 1H), 5.63-5.60 (m, 1H), 5.28 (dd, J =17.2, 1.4 
Hz, 1H), 5.16 (dd, J= 10.2, 1.4 Hz, 1H), 3.99-3.93 (m, 1H), 3.82-3.78 (m, 3H), 2.93 (s, 3H), 
2.13-2.05 (m, 1H), 1.98-1.85 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 135.5, 117.1, 88.7, 68.2, 45.4, 39.7, 29.4, 25.0. 
HRESI-MS: calculated for (C8H15NO3S, M+Na), 228.0670; found, 228.0668. 
 
 
N-(1-phenylethyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide   
Isolated by gradient elution from the column with hexane-EtOAc (20:1 to 9:1) in 75 % yield 
as white solid. Diastereomeric ratio is 2:3 (3f:3g). 
N-(1-phenylethyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (d.r- 2:3) major 
product (3f)  
1
H NMR (400 MHz, CD2Cl2): 7.55 (d, J = 7.6 Hz, 2H), 7.38-7.27 (m, 3H), 5.48 (m, 1H), 
4.89 (q, J = 7.24 Hz, 1H), 4.11-4.06 (m, 1H), 3.80-3.75 (m, 1H), 2.45 (s, 3H), 2.12-2.02 (m, 
3H), 1.96-1.88 (m, 1H), 1.73 (d, J = 7.2 Hz, 3H). 
13
C NMR (101 MHz, CD2Cl2): 140.1, 129.00, 128.5, 128.00, 89.3, 67.9, 54.6, 42.4, 30.8, 
25.5, 21.1. 
HRESI-MS: calculated for (C13H19NO3S, M+Na), 292.0983; found, 292.0981. 
 
N-(1-phenylethyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (d.r- 2:3) minor 
product (3g) 
Contains 15% of major isomer. 
1
H NMR (400 MHz, CD2Cl2): 7.41-7.24 (m, 5H), 5.06-5.02 (m, 2H), 4.03-3.98 (m, 1H), 
3.71-3.66 (m, 1H), 3.04 (s, 3H), 2.28-2.22 (m, 1H), 2.02-1.97 (m, 1H), 1.77-1.72 (m, 5H). 
13
C NMR (101 MHz, CD2Cl2): 142.2, 128.7, 127.5, 127.4, 89.3, 68.5, 55.6, 53.8, 43.8, 31.34, 
25.5, 17.9. 
Elemental analysis: Anal. Calcd for C13H19NO3S: C, 57.97; H, 7.11; N 5.20. Found: C, 
57.64; H, 7.20; N 4.88. 
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N-phenyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3h) 
Eluated from the column with CH2Cl2 in 59 % yield as a white solid. 
1
H NMR (400 MHz, CDCl3): 7.46-7.44 (m, 2H), 7.42-7.27 (m, 3H), 6.03-6.00 (dd, J = 7.1, 
6.0 Hz, 1H), 3.92-3.87 (m, 1H), 3.78-3.72 (m, 1H), 3.07 (s, 3H), 2.13-2.04 (m, 1H), 1.77-1.59 
(m, 2H), 1.46-1.36 (m, 1H). 
13
C NMR (101 MHz, CDCl3): 136.2, 131.4, 129.3, 129.1, 89.5, 68.4, 39.8, 29.7, 24.8. 
HRESI-MS: calculated for (C11H15NO3S, M+H), 242.0851; found, 242.0853. 
 
 
N-hexyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3i) 
Eluated from the column with hexane-EtOAc (9:1) in 67% yield as a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.78 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.1, 2H), 5.80-5.76 (m, 
1H), 3.91-3.85 (m, 1H), 3.76-3.71 (m, 1H), 3.02-2.88 (m, 2H), 2.41 (s, 3H), 2.17-2.11 (m, 
1H), 1.95-1.76 (m, 4H), 1.61-1.50 (m, 1H), 1.32-1.19 (m, 6H), 0.88 (t, J = 6,7 Hz, 3H). 
13
C NMR (101 MHz, CDCl3): 143.2, 137.2, 129.5, 127.8, 88.8, 68.1, 43.4, 31.5, 31.5, 30.3, 
26.9, 25.0, 22.7, 21.6, 14.1. 
HRESI-MS: calculated for (C17H27NO3S, M+Na), 348.1609; found, 348.1610. 
 
 
N-cyclohexyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3j) 
Eluated from the column with hexane-EtOAc (9:1) in 43% yield as a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.81 (d, J = 8.3 Hz, 2H), 7.25 (d, J = 8.6 Hz, 2H), 5.44-5.30 
(m, 1H), 4.11-4.06 (m, 1H), 3.80-3.76 (m, 1H), 3.30-3.26 (m, 1H), 2.40 (s, 3H), 2.35-2.29 
(m, 1H), 2.15-2.07 (m, 2H), 1.95-1.43 (m, 8H), 1.26-0.99 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 142.8, 140.0, 129.4, 127.4, 88.8, 68.1, 57.7, 33.8, 31.4, 26.7, 
25.5, 25.4, 21.6. 
HRESI-MS: calculated for (C17H25NO3S, M+H), 324.1633; found, 324.1639. 
 
 
N-isopropyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3k) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 4:1) in 63 % yield as 
a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.72 (d, J = 8.3 Hz, 2H), 7.17 (d, J = 8.1 Hz, 2H), 5.30 (t, J = 
7.0 Hz, 1H), 4.02-3.96 (m, 1H), 3.72-3.63 (m, 2H), 2.31 (s, 3H), 2.28-2.22 (m, 1H), 2.08-2.01 
(m, 2H), 1.85-1.77 (m, 1H), 1.19 (d, J = 6.8 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H). 
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13
C NMR (101 MHz, CDCl3): 142.8, 139.7, 129.4, 127.5, 88.3, 68.0, 49.1, 31.3, 25.4, 23.4, 
21.6, 21.0. 
HRESI-MS: calculated for (C14H21NO3S, M+H), 284.1320; found 284.1316. 
 
 
N-allyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3l) 
Eluated from the column with hexane-EtOAc (3:1) in 73 % yield as a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.78 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 5.93-5.84 
(m, 2H), 5.23 (dd, J = 17.2, 1.2 Hz, 1H), 5.10 (dd, J = 10.0, 1.2 Hz, 1H), 3.90-3.84 (m, 1H), 
3.76-3.67 (m, 3H), 2.42 (s, 3H), 2.16-2.08 (m, 1H), 2.00-1.85 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 143.3, 137.1, 136.0, 129.5, 127.8, 116.4, 88.8, 68.3, 45.2, 
30.0, 25.0, 21.6. 
HRESI-MS: calculated for (C14H19NO3S, M+H), 282.1164; found, 282.1166. 
 
 
N-(2,2-dimethylpent-4-en-1-yl)-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide 
(3m) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 6:1) in 62% yield as 
a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.77 (d, J = 8.2 Hz, 2H), 7.28 (d, J = 8.2 Hz, 2H), 5.89-5.78 
(m, 1H), 5.27-5.24 (m, 1H), 5.08-5.02 (m, 2H), 4.00-3.95 (m, 1H), 3.71-3.67 (m, 1H), 3.27 
(d, J = 15.2 Hz, 1H), 2.83 (d, J = 15.2 Hz, 1H), 2.42 (s, 3H), 2.36-2.27 (m, 1H), 2.14-2.06 (m, 
1H), 1.90-1.81 (m, 1H), 0.99 (s, 6H). 
13
C NMR (101 MHz, CDCl3): 143.1, 138.4, 135.1, 129.3, 127.90 117.7, 93.1, 68.0, 57.7, 
45.9, 35.2, 31.3, 26.2, 25.8, 25.0, 21.6. 
HRESI-MS: calculated for (C18H27NO3S, M+Na), 360.1609; found, 360.1611 
 
 
N-benzyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3n) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 4:1) in 61% yield as 
a white solid. 
1
H NMR (400 MHz, CDCl3): 7.81 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 7.5 Hz, 2H), 7.35-7.27 
(m, 5 H), 5.95-5.92 (m , 1H), 4.44 (d, J = 17.0 Hz, 1H), 4.15 (d, J = 17.0 Hz, 1H), 3.91-3.86 
(m, 1H), 3.78-3.73 (m, 1H), 2.44 (s, 3H), 2.03-1.97 (m, 1H), 1.95-1.64 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 143.4, 138.5, 136.9, 129.5, 128.5, 127.8, 127.2, 127.1, 88.9, 
68.5, 46.0, 30.2, 24.8, 21.6. 
HRESI-MS: calculated for (C18H21NO3S, M+H), 332.1320; found, 332.1311 
 
 
N-(2,2-dimethylpent-4-en-1-yl)-N-(tetrahydrofuran-2-yl)acetamide (5a) 
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Eluated from the column with hexane-EtOAc (5:1) in 54 % yield as a pale yellow oil. 
1
H NMR (400 MHz, CD2Cl2): 5.91-5.80 (m, 1H), 5.35 (br, 1H), 5.03-4.99 (m, 2H), 3.98 (m, 
1H), 3.74-3.69 (m, 1H), 3.38 (d, J = 13.5 Hz, 1H), 3.04 (d, J = 13.5 Hz, 1H), 2.13-1.92 (m, 
9H), 0.87 (s, 6H) 
13
C NMR (101 MHz, CD2Cl2): 172.5, 136.1, 117.1, 90.7, 67.3, 52.7, 46.3, 36.0, 30.1, 26.0, 
25.8, 25.4, 23.2. 
HRESI-MS: calculated for (C13H23NO2, M+H), 226.1807; found 226.1811. 
 
N-allyl-N-(tetrahydrofuran-2-yl)acetamide (5b) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 6:1) in 82% as a 
colorless oil. 
1
H NMR (400 MHz, DMSO-d6, 373K): 5.87-5.73 (m, 2H), 5.12 (dd, J = 17.4, 1.4 Hz, 1H), 
5.07 (dd, J = 10.4, 1.4 Hz, 1H), 3.93-3.84 (m, 3H), 3.71-3.67 (m, 1H), 2.07-2.02 (m, 4H), 
1.98-1.82 (m, 3H). 
13
C NMR (101 MHz, DMSO-d6, 373K): 170.2, 135.5, 114.3, 86.1, 66.4, 43.3, 28.3, 24.1, 
21.0. 
HRESI-MS: calculated for (C9H15NO2, M+Na), 192.1001; found 192.1008. 
 
 
N-benzyl-N-(tetrahydrofuran-2-yl)acetamide (5c) 
Eluated from the column with hexane-EtOAc (4:1) in 71 % yield as an off-white solid. 
1
H NMR (400 MHz, DMSO-d6, 373K): 7.30-7.21 (m, 5H), 5.84 (m, 1H), 4.58 (d, J = 16.7 
Hz, 1H), 4.40 (d, J = 16.7 Hz, 1H), 3.90-3.85 (m, 1H), 3.72-3.67 (m, 1H), 2.08-2.01 (m, 4H), 
1.91-1.73 (m, 3H). 
13
C NMR (101 MHz, DMSO-d6, 373K): 170.1, 138.9, 127.4, 126.7, 125.8, 86.6, 66.4, 44.4, 
28.5, 24.1, 21.2. 
HRESI-MS: calculated for (C13H17NO2, M+H), 220.1338; found 220.1341. 
 
 
N-phenyl-N-(tetrahydrofuran-2-yl)acetamide (5d) 
Isolated by gradient elution from the column with hexane-EtOAc (4:1 to 2:1) in 95 % yield as 
a white solid  
1
H NMR (400 MHz, CD2Cl2): 7.43-7.20 (m, 5H), 6.45 (br, 1H), 3.63-3.60 (m, 2H), 2.03-1.98 
(m, 1H), 1.72-1.62 (m, 5H), 1.25-1.22 (m, 1H). 
13
C NMR (101 MHz, CD2Cl2): 171.1, 139.5, 131.0, 129.5, 128.6, 84.4, 68.4, 29.5, 25.3, 23.6. 
HRESI-MS: calculated for (C12H15NO2, M+H), 206.1181; found 206.1177. 
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2,2,2-trifluoro-N-hexyl-N-(tetrahydrofuran-2-yl)acetamide (5e) 
Isolated by gradient elution from the column with hexane-EtOAc (20:1 to 10:1) in 62% yield 
as a colorless oil. 
1
H NMR (400 MHz, DMSO-d6, 373K): 5.63-5.60 (m, 1H) 4.05-3.99 (m, 1H), 3.82-3.77 (m, 
1H), 3.41-3.34 (m, 1H), 3.26-3.19 (m, 1H), 2.25-2.20 (m, 1H), 2.03-1.92 (m, 3H), 1.68-1.52 
(m, 2H), 1.35-1.29 (m, 6H), 0.89 (t, J = 6.5 Hz, 3H). 
13
C NMR (101 MHz, DMSO-d6, 373K): 155.1 (q, J = 35 Hz), 115.7 (q, J = 289 Hz), 87.0, 
67.7, 42.3, 30.0, 29.2, 27.5, 25.4, 24.0, 21.1, 12.7. 
HRESI-MS: calculated for (C12H20F3NO2, M+Na), 290.1344; found, 290.1348. 
 
 
N-(tert-butyl)-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5f) 
Eluated from the column with hexane-EtOAc (5:1) in 58% yield as a colorless oil. 
1
H NMR (400 MHz, CD2Cl2): 5.40 (m, 1H), 4.06-4.01 (m, 1H), 3.71-3.65 (m, 1H), 2.20-2.08 
(m, 3H), 1.99-1.93 (m, 1H), 1.49 (s, 9H) 
13
C NMR (101 MHz, CD2Cl2): 159.1 (q, J = 37 Hz), 117.0 (q, J = 290 Hz), 88.9, 67.0, 60.2, 
31.1, 28.8, 24.7. 
HRESI-MS: calculated for (C10H16F3NO2, M+Na), 262.1031; found, 262.1035. 
 
 
N-allyl-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5g) 
Eluated from the column with hexane-EtOAc (9:1) in 80 % yield as a yellowish oil. 
1
H NMR (400 MHz, DMSO-d6, 373K): 5.90-5.81 (m, 1H), 5.70-5.67 (m, 1H), 5.22-5.13 (m, 
2H), 4.05-3.99 (m, 3H), 3.82-3.77 (m, 1H), 2.26-2.18 (m, 1H), 2.08-1.90 (m, 3H) 
13
C NMR (101 MHz, DMSO-d6, 373K): 155.3 (q, J = 35 Hz), 133.3, 115.7, 115.6 (q, J = 
290 Hz), 86.8, 67.7, 43.9, 29.0, 23.9. 
HRESI-MS: calculated for (C9H12F3NO2, M+Na), 246.0718; found, 246.0720. 
 
 
N-benzyl-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5h) 
Isolated by gradient elution from the column with hexane-EtOAc (3:1 to 2:1) in 89 % yield as 
slightly yellowish oil. 
S13 
 
1
H NMR (400 MHz, CD2Cl2): 7.25-7.15 (m, 5H), 5.70 (m, 1H), 4.54 (d, J = 15.7 Hz, 1H), 
4.38 (d, J = 15.8 Hz, 1H), 3.97-3.91 (m, 1H), 3.77-3.72 (m, 1H), 2.11-2.03 (m, 1H), 1.91-
1.72 (m, 3H). 
13
C NMR (101 MHz, CD2Cl2): 157.2 (q, J = 36 Hz), 137.5, 128.9, 127.6, 127.1, 117.0 (q, J = 
289 Hz), 87.9, 69.2, 45.9, 30.5, 25.7. 
HRESI-MS: calculated for (C13H14F3NO2, M+Na), 296.0874; found, 296.0873. 
 
 
Ethyl-4-(N-(tetrahydrofuran-2-yl)acetamido)benzoate (5i) 
Eluated from the column with hexane-EtOAc (3:1) in 93 % yield as a colorless oil. 
1
H NMR (400 MHz, CD2Cl2): 8.07 (d, J = 8.5 Hz, 2H), 7.38-7.27 (br, 2H), 6.48-6.36 (br, 
1H), 4.37 (q, J = 7.1 Hz, 2H), 3.65-3.61 (m, 2H), 2.08-2.00 (m, 1H), 1.78-1.58 (br+m, 5H), 
1.38 (t, J = 7.1 H, 3H), 1.30-1.23 (m, 1H). 
13
C NMR (101 MHz, CD2Cl2) δ 170.7, 166.1, 143.7, 131.0, 130.7, 118.8, 85.1, 68.5, 61.6, 
29.7, 25.3, 23.63, 14.5. 
HRESI-MS: calculated for (C15H19NO4, M+Na), 300.1212; found 300.1206. 
 
 
N-(4-cyanophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5j) 
Isolated by gradient elution from the column with hexane-EtOAc (4:1 to 3:2) in 89 % yield as 
a colorless oil. 
1
H NMR (400 MHz, CD3CN): 7.79 (d, J = 7.4 Hz, 2H), 7.43 (d, J = 7.6 Hz, 2H), 6.27 (br, 
1H), 3.61 (m, 2H), 2.08-1.99 (m, 1H), 1.76-1.54 (m, 5H), 1.27-1.18 (m, 1H). 
13
C NMR (101 MHz, CD3CN): 171.5, 144.26, 134.1, 132.5, 119.1, 112.7, 85.9, 68.7, 29.9, 
25.4, 23.5. 
HRESI-MS: calculated for (C13H14N2O2, M+Na), 253.0953; found 253.0956. 
 
 
N-(tetrahydrofuran-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide (5k) 
Eluated from the column with hexane-EtOAc (7:3) in 95 % yield as a colorless oil. 
1
H NMR (400 MHz, CD2Cl2): 7.69 (d, J = 8.1 Hz, 2H), 7.48-7.35 (br, 2H), 6.51-6.32 (br, 
1H), 3.68-3.63 (m, 2H), 2.10-2.00 (m, 1H), 1.87-1.55 (m, 5H), 1.33-1.23 (m, 1H). 
13
C NMR (101 MHz, CD2Cl2): 170.7, 143.0, 131.6, 130.6 (q, J = 32 Hz), 126.7, 124.4 (q, J = 
273 Hz), 84.9, 68.4, 29.6, 25.3, 23.6. 
HRESI-MS: calculated for (C13H14F3NO2, M+Na), 296.0874; found 296.0865. 
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N-(4-bromophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5l) 
Isolated by gradient elution from the column with hexane-EtOAc (4:1 to 2:1) in 95 % yield as 
a white solid  
1
H NMR (400 MHz, CD2Cl2): 7.55 (d, J = 8.2 Hz, 2H), 7.30-6.99 (br, 2H), 6.42 (br, 1H), 
3.66-3,60 (m, 2H), 2.07-1.98 (m, 1H), 1.82-1.57 (m, 5H), 1.34-1.24 (m, 1H). 
13
C NMR (101 MHz, CD2Cl2): 170.8, 138.6, 132.7, 122.6, 84.4, 68.4, 29.6, 25.3, 23.7. 
HRESI-MS: calculated for (C12H14BrNO2, M+Na), 306.0106; found 306.0117. 
 
 
N-(4-iodophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5m) 
Isolated by gradient elution from the column with hexane-EtOAc (4:1 to 2:1) in 90 % yield as 
a white solid  
1
H NMR (400 MHz, CD3CN): 7.78 (d, J = 8.2 Hz, 2H), 7.07-7.03 (br, 2H), 6.42-6.32 (br, 
1H), 3.60-3.54 (m, 2H), 2.03-1.94 (m, 1H), 1.77-1.56 (m, 1H), 1.26-1.20 (m, 1H). 
13
C NMR (101 MHz, CD3CN): 171.0, 140.0, 139.3, 133.8, 94.3, 84.8, 68.7, 29.9, 25.5, 23.6. 
HRESI-MS: calculated for (C12H14INO2, M+H), 332.0148; found 332.0164. 
 
 
N-(4-methoxyphenyl)-N-(tetrahydrofuran-2-yl)acetamide (5n) 
Eluated from the column with hexane-EtOAc (4:1) in 93 % yield as a beige solid. 
1
H NMR (400 MHz, CD2Cl2): 7.26 (br, 1H), 7.05 (br, 1H), 6.91 (d, J = 8.24 Hz, 2H), 6.38 
(m, 1H), 3.82 (s, 3H), 3.67-3.63 (m, 2H), 2.05-1.95 (m, 1H), 1.76-1.63 (m, 5H), 1.31-1.24 
(m, 1H) 
13
C NMR (101 MHz, CD2Cl2): 172.5, 159.8, 131.9, 122.0, 114.6, 84.6, 68.5, 55.8, 29.4, 25.3, 
23.6. 
HRESI-MS: calculated for (C13H17NO3, M+H), 236.1287; found 236.1278. 
 
 
N-(6-methylpyridin-2-yl)-N-(tetrahydrofuran-2-yl)acetamide (5o) 
Isolated by gradient elution from the column with hexane-EtOAc (10:1 to 2:1) in 86 % yield 
as a colorless oil. 
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1
H NMR (400 MHz, CD2Cl2): 7.69 (t, J = 7.7 Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 7.11 (d, J = 
7.7 Hz, 1H), 6.31-6.28 (m, 1H), 3.74-3.65 (m, 2H), 2.53 (s, 3H), 2.08-2.00 (m, 1H), 1.80-1.66 
(m, 5H), 1.37-1.25 (m, 1H). 
13
C NMR (101 MHz, CD2Cl2): 171.9, 159.4, 152.3, 139.0, 123.4, 122.1, 85.7, 68.6, 29.3, 
25.1, 24.3, 23.5. 
HRESI-MS: calculated for (C12H16N2O2, M+H), 221.1290; found 221.1292. 
 
 
2-(tetrahydrofuran-2-yl)isoindoline-1,3-dione (5p) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 6:1) in 75% yield as 
a white solid. 
1
H NMR (400 MHz, CDCl3): 7.86 (m, 2H), 7.73 (m, 2H), 6.06-6.03 (m, 1H), 4.23-4.16 (m, 
1H), 3.96-3.93 (m, 1H), 2.57-2.50 (m, 1H), 2.42-2.24 (m, 2H), 2.04-1.98 (m, 1H). 
13
C NMR (101 MHz, CDCl3): 168.0, 134.3, 132.0, 123.5, 81.0, 67.0, 29.3, 26.2. 
HRESI-MS: calculated for (C12H11NO4, M+H), 218.0817; found, 218.0812 
 
 
1-(Tetrahydrofuran-2-yl)-1H-imidazole (7a) 
Isolated by flash column chromatography (methanol/ dichloromethane = 1:10) in 52% as 
colorless oil. 
1
H and 
13
C NMR spectra of the compound correspond to that published before.
6 
 
 
1-(Tetrahydrofuran-2-yl)-1H-benzo[d]imidazole (7b) 
Isolated by flash column chromatography (methanol/ dichloromethane = 1:10) in 85% yield 
as colorless oil. 
1
H and 
13
C NMR spectra of the product correspond to that published before.
6
 
 
 
N-[Tetrahydrofuran-2-yl]-1H-indole (7c) 
Isolated by gradient elution from the column with hexane-EtOAc (20:1 to 9:1) in 57% yield 
as a colorless liquid. 
1
H NMR (400 MHz, CD2Cl2): 7.59 (d, J = 7.7 Hz, 1H), 7.46 (d, J = 8.2 Hz, 1H),7.25 – 
7.18 (m, 2H ), 7.12 (dd, J = 7.6, 7.6 Hz, 1H), 6.51 (d, J = 3.0 Hz, 1H), 6.22 ( dd, J = 5.7, 
4.2 Hz, 1H), 4.13-4.07 (m, 1H), 4.00-3.94 (m, 1H), 2.47-2.37 (m, 2H), 2.23-2.08 (m, H-
2H). 
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13
C NMR (101 MHz, CD2Cl2): 136.1, 129.5, 124.5, 122.0, 121.1, 120.2, 110.4, 102.4, 86.2, 
68.7, 31.9, 25.2. 
GCMS: [M] =187 detected which corresponds to C12H13NO; the purity was further 
confirmed by GCMS. 
 
 
9-(tetrahydrofuran-2-yl)-9H-carbazole (7d) 
Isolated by gradient elution from the column with hexane-EtOAc (15:1 to 9:1) in 65% yield 
as a white solid 
1
H NMR (400 MHz, CDCl3): 8.10 (d, J = 8.48 Hz, 2H), 7.54-7.39 (m, 4H), 7.29-7.24 (m, 
2H), 6.52-6.49 (m, 1H), 4.44-4.39 (m, 1H), 4.10-4.06 (m, 1H), 2.56-2.47 (m, 1H), 2.42-2.20 
(m, 3H). 
13
C NMR (101 MHz, CDCl3): 139.1, 125.8, 123.9, 120.4, 119.7, 110.5, 86.6, 68.2, 29.5, 
25.8. 
HRESI-MS: calculated for (C16H15NO, M+H), 238.1232; found, 238.1241 
 
 
N-benzyl-N-(1,4-dioxan-2-yl)methanesulfonamide (8a) 
Isolated by gradient elution from the column with hexane-EtOAc (6:1 to 4:1) in 47 % yield as 
a beige solid. 
1
H NMR (400 MHz, CD2Cl2): 7.39-7.24 (m, 5H), 5.20-5.17 (m, 1H), 4.54 (d, J = 16.6 Hz, 
1H), 4.43 (d, J = 16.6 Hz, 1H), 3.87-3.83 (m, 2H), 3.61-3.58 (m, 1H), 3.48-3.40 (m, 2H), 
3.26-3.21 (m, 1H), 2.97 (s, 3H). 
13
C NMR (101 MHz, CD2Cl2): 138.6, 128.9, 127.8, 127.6, 83.4, 69.3, 67.3, 66.0, 47.8, 40.3. 
HRESI-MS: calculated for (C12H17NO4S, M+Na), 294.0776; found 294.0779. 
 
 
2-(1,4-dioxan-2-yl)isoindoline-1,3-dione (8b) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 4:1) in 85% yield as 
a white solid. 
1
H NMR (400 MHz, CDCl3): 7.87 (m, 2H), 7.76 (m, 2H), 5.56-5-53 (m, 1H), 4.61-4.56 (m, 
1H), 3,98-3.95 (m, 2H), 3.78-3-76 (m, 3H). 
13
C NMR (101 MHz, CDCl3): 167.2, 134.6, 131.7, 123.8, 76.3, 67.7, 66.5, 65.8. 
HRESI-MS: calculated for (C12H11NO4, M+H), 234.0766; found, 234.0768. 
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N-benzyl-N-(tetrahydro-2H-pyran-2-yl)methanesulfonamide (8c) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 6:1) in 68 % yield as 
a white solid. 
1
H NMR (400 MHz, CD2Cl2): 7.39-7.24 (m, 5H), 5.03-5.01 (m, 1H), 4.53-4.40 (m, 2H), 
4.01-3.98 (m, 1H), 3.59-3.53 (m, 1H), 2.93 (s, 3H), 1.79-1.76 (m, 1H), 1.56-1.36 (m, 5H) 
13
C NMR (101 MHz, CD2Cl2): 139.4, 128.7, 127.4, 127.4, 86.8, 68.4, 47.1, 40.0, 31.4, 25.4, 
23.9. 
HRESI-MS: calculated for (C13H19NO3S, M+Na), 292.0983; found 292.0977. 
 
 
2-(tetrahydro-2H-pyran-2-yl)isoindoline-1,3-dione 31 (8d) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 6:1) in 43 % yield as 
a white solid. 
1
H NMR (400 MHz, CD2Cl2): 7.85 (m, 2 H), 7.74 (m, 2H), 5.30-5.26 (m, 1H), 4.06-4.03 (m, 
1H), 3.65-3.59 (m, 1H), 2.76-2.66 (m, 1H), 2.02-1.98 (m, 1H), 1.71-1.52 (m, 4H). 
13
C NMR (101 MHz, CD2Cl2): 167.7, 134.6, 132.2, 123.7, 79.6, 69.2, 28.2, 25.4, 24.0. 
HRESI-MS: calculated for (C13H13NO3, M+H), 232.0974; found 232.0963. 
 
 
N-allyl-N-(5-methyltetrahydrofuran-2-yl)methanesulfonamide (8e) 
Isolated by gradient elution from the column with hexane-EtOAc (20:1 to 10:1) in 61 % yield 
as a colorless oil. The ratio of two diastereomers is 2:3. 
1
H NMR (400 MHz, CD2Cl2): 6.00-5.89 (m, 1Hoverlap), [5.68-5.65 (m, 0.6Hmayor), 5.57-5.54 
(m, 0.4Hminor)], 5.30 (m, 1Hoverlap), 5.16 (m, 1Hoverlap), [4.26-4.20 (m, 0.6Hmayor), 3.97-3.92 
(m, 0.4Hminor)], 3.85-3.73 (m, 2Hoverlap) 2.90 (s. 3Hoverlap), 2.16-1.92 (m, 3Hoverlap), 1.53-1.41 
(m, 1Hoverlap), [1.26 (d, J = 6.0 Hz, 1.2Hminor), 1.18 (d, J = 6.0 Hz, 1.8Hmayor).] 
13
C NMR (101 MHz, CD2Cl2): 136.3, 136.1, 116.8, 116.7, 88.8, 88.6, 76.7, 75.1, 45.8, 45.7, 
39.9, 39.8, 33.2, 32.0, 30.9, 29.8, 21.7, 21.00 
HRESI-MS: calculated for (C9H17NO3S, M+Na), 242.0827; found 242.0818. 
 
 
N-benzyl-N-(1,2-dimethoxyethyl)methanesulfonamide (8f) 
Isolated by gradient elution from the column with hexane-EtOAc (9:1 to 4:1) in 50 % yield as 
a colorless oil 
1
H NMR (400 MHz, CD2Cl2): 7.43-7.28 (m, 5H), 5.11-5.08 (m, 1H), 4.43 (d, J = 15.8 Hz, 
1H), 4.29 (d, J = 15.8 Hz, 1H), 3.47 (m, 2H), 3.32 (s, 3H), 3.25 (s, 3H), 2.77 (s, 3H). 
13
C NMR (101 MHz, CD2Cl2): 138.1, 129.0, 128.7, 127.8, 87.8, 71.8, 59.0, 55.9, 46.0, 41.9. 
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HRESI-MS: calculated for (C12H19NO4S, M+Na), 296.0933; found 296.0942. 
 
 
N-benzyl-N-(1,2-dimethoxyethyl)-2,2,2-trifluoroacetamide (8g) 
Isolated by gradient elution from the column with hexane-EtOAc (10:1 to 5:1) in 41 % yield 
as a colorless oil. 
1
H NMR (400 MHz, CD2Cl2): 7.32-7.26 (m, 5H), 5.16 (m, 1H), 4.68 (d, J = 15.3 Hz, 1H), 
4.53 (d, J = 15.3 Hz, 1H), 3.47-3.40 (m, 1H), 3.34-3.28 (m, 4H), 3.17 (s, 3H). 
13
C NMR (101 MHz, CD2Cl2): 156.7 (q, J = 33 Hz), 137.3, 128.7, 128.2, 119.7 (q, J = 289 
Hz), 87.3, 72.1, 59.1, 56.2, 44.7. 
HRESI-MS: calculated for (C13H16F3NO3, M+Na), 314.0980; found 314.0975. 
  
N-benzyl-2,2,2-trifluoro-N-((2-methoxyethoxy)methyl)acetamide (8g’) 
Isolated by gradient elution from the column with hexane-EtOAc (10:1 to 5:1) in 20 % yield 
as a colorless oil. 
1
H NMR (400 MHz, CD2Cl2): 7.39-7.23 (m, 5H), 4.81 (d, J = 14.9 Hz, 2H), 4.70 (s, 2H), 
3.62-3.50 (m, 2H), 3.48 (m, 2H), 3.33 (s, 3H) 
13
C NMR (101 MHz, CD2Cl2): 157.3 (q, J = 34 Hz), 135.9, 129.1, 128.8, 128.3, 116.8 (q, J = 
287 Hz), 77.0, 72.0, 68.0, 59.1, 48.5. 
HRESI-MS: calculated for (C13H16F3NO3, M+Na), 314.0980; found 314.0974. 
 
 
N-allyl-N-(1,2-dimethoxyethyl)methanesulfonamide (8h) 
Eluated from the column with hexane-EtOAc (7:3) in 56 % yield as a colorless oil 
1
H NMR (400 MHz, CD2Cl2): 5.90-5.81 (m, 1H), 5.28 (dd, J = 17.2 Hz, 1.5 Hz, 1H), 5.17 
(dd, J = 10.2 Hz, 1.3 Hz, 1H), 5.03 (m, 1H), 3.83 (d, J = 6.28 Hz, 2H), 3.49-3.39 (m, 2H), 
3.34 (s, 3H), 3.30 (s, 3H), 2.91 (s, 3H). 
13
C NMR (101 MHz, CD2Cl2): 135.5, 118.1, 87.3, 71.8, 59.0, 55.5, 44.4, 42.5. 
HRESI-MS: calculated for (C8H17NO4S, M+Na), 246.0776; found 246.0780. 
 
 
3-(4-methoxybenzyl)-5-methylpyrimidine-2,4(1H,3H)-dione (9a) 
1
H NMR (400 MHz, CDCl3): 9.59 (br, 1H), 7.43 (d, J = 8.3 Hz, 2H), 6.99 (d, J = 5.2 Hz, 
1H), 6.83 (d, J = 8.3 Hz, 2H), 5.05 (s, 2H), 3.77 (s, 3H), 1.92 (s, 3H). 
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13
C NMR (101 MHz, CDCl3): 164.1, 159.2, 153.1, 134.3, 130.7, 129.1, 113.8, 110.5, 55.4, 
43.5, 13.2. 
HRESI-MS: calculated for (C13H14N2O3, M+H), 247.1083; found 247.1088. 
 
 
3-(4-methoxybenzyl)-5-methyl-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione (10a) 
Isolated by gradient elution from the column with hexane-EtOAc (10:1 to 4:1) in 85 % yield 
as white solid. 
1
H NMR (101 MHz, CD2Cl2): 7.36 (d, J = 8.5 Hz, 2H), 7.11 (s, 1H), 6.81 (d, J = 8.5 Hz, 
2H), 6.01 (dd, J = 6.1, 2.9 Hz, 1H), 5.04-4.96 (m, 2H), 4.20-4.15 (m, 1H), 3.95-3.90 (m, 1H), 
3.75 (s, 3H), 2.39-2.29 (m, 1H), 2.03-1.90 (m, 6H). 
13
C NMR (101 MHz, CD2Cl2): 163.8, 159.4, 151.2, 133.6, 130.6, 129.9, 113.8, 109.7, 87.7, 
70.3, 55.6, 43.9, 33.0, 24.5, 13.5. 
HRESI-MS: calculated for (C17H20N2O4, M+H), 317.1501; found 317.1509. 
 
 
di-tert-butyl 5-fluoro-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate (9b’) 
Recrystallized from hexane-EtOAc (10:1) in 68 % yield 
1
H NMR (400 MHz, CDCl3): 7.97 (d, J = 6.44 Hz, 1H), 1.60 (s, 18H) 
13
C NMR (101 MHz, CDCl3): 154.5 (d, J = 28.8 Hz), 147.5, 146.1, 144.2, 139.9 (d, J = 
243.4 Hz), 123.4 (d, J = 37.0 Hz), 88.4, 88.2, 27.9, 27.5. 
HRESI-MS: calculated for (C14H19FN2O6, M+Na), 353.1125; found 353.1130. 
 
 
 
tert-butyl 5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate (9b) 
Isolated by flash cromatography on silica gel (eluent - hexane-EtOAc 3:2) in 40% yield 
1
H NMR (400 MHz, DMSO-d6): 11.53 (s, 1H), 7.98 (d, J = 6.04 Hz, 1H), 1.51 (s, 9H). 
13
C NMR (101 MHz, DMSO-d6): 155.1 (d, J = 28.0 Hz), 147.5, 147.1, 139.1 (d, J = 229.3 
Hz), 127.4 ( d, J = 38.0 Hz), 86.6, 27.0. 
HRESI-MS: calculated for (C9H11FN2O4, M+Na), 253.0601; found 253.0611. 
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tert-butyl-5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-3,6-dihydropyrimidine-1(2H)-
carboxylate (10b) 
Isolated by gradient elution from the column with hexane-EtOAc (10:1 to 5:2) in 81 % yield 
as a white solid. 
1
H NMR (400 MHz, CDCl3): 7.42 (d, J = 6.12 Hz, 1H), 5.97-5.95 (m, 1H), 4.27-4.22 (m, 
1H), 4.04-3.98 (m, 1H), 2.47-2.37 (m, 1H), 2.18-2.05 (m, 2H), 1.97-1.90 (m, 1H), 1.62 (s, 
9H) 
13
C NMR (101 MHz, CDCl3): 154.8 (d, J = 28.0 Hz), 146.8, 146.7, 139.9 (d, J = 238.0 Hz), 
123.2 (d, J = 34.2 Hz), 88.2, 87.8, 70.6, 33.1, 27.5, 23.8. 
HRESI-MS: calculated for (C13H17FN2O5, M+Na), 323.1019; found 323.1012. 
 
 
5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione (Tegafur) 
N3-Boc-N1-tetrahydrofuranyl-5-fluorouracil (10b) (60 mg, 0.2 mmol) was heated to 75˚C in 
2 mL of isopropanol for 4h. The evaporation of the solvent under reduced pressure gave 5-
fluoro-1-(tetrahydro-2-furyl)-2,4(1H,3H)-pyrimidinedione in quantative yield (40 mg). 
1
H NMR (400 MHz, DMSO-d6): 11.77 (br, 1H), 7.87 (d, J = 6.96 Hz, 1H), 5.90-5.88 (m, 
1H), 4.24-4.19 (m, 1H), 3.81-3.75 (m, 1H), 2.25-2.17 (m, 1H), 2.03-1.87 (m, 3H) 
13
C NMR (101 MHz, DMSO-d6): 157.2 (d, J = 26.3 Hz), 148.9, 139.9 (d, J = 231.0 Hz), 
125.0 (d, J = 34.0 Hz), 86.3, 69.3, 31.5, 23.7. 
 
 
tert-butyl 5-fluoro-2,6-dioxo-3-(tetrahydro-2H-pyran-2-yl)-3,6-dihydropyrimidine-
1(2H)-carboxylate (10c) 
1
H NMR (400 MHz, CDCl3): 7.50 (d, J = 6.1 Hz, 1H), 5.55-5.51 (m, 1H), 4.16-4.12 (m, 1H), 
3.69-3.62 (m, 1H), 2.02-1.94 (m, 2H), 1.63-1.57 (m, 2H), 1.61 (s, 9H), 1.51-1.41 (m, 2H). 
13
C NMR (101 MHz, CDCl3): 154.6 (d, J = 28 Hz), 146.9, 146.7, 140.2 (d, J = 239 Hz), 
123.8 (d, J = 34 Hz), 87.8, 83.1, 69.4, 31.2, 27.6, 24.9, 22.6. 
HRESI-MS: calculated for (C13H17FN2O6, M+Na), 337.1176; found 337.1171. 
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tert-butyl 3-(1,4-dioxan-2-yl)-5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-
carboxylate (10d) 
1
H NMR (400 MHz, CDCl3): 7.64 (d, J = 6.0 Hz, 1H), 5.72-5.70 (m, 1H), 4.03-3.99 (m, 2H), 
3.95-3.90 (m, 1H), 3.81-3.77 (m, 1H), 3.70-3.63 (m, 1H), 3.43-3.38 (m, 1H), 1.60 (s, 9H). 
13
C NMR (101 MHz, CDCl3): 154.4 (d, J = 28 Hz), 146.9, 146.4, 140.1 (d, J = 238 Hz), 
123.9 (d, J = 35 Hz), 88.1, 78.9, 68.2, 66.8, 65.8, 27.5. 
HRESI-MS: calculated for (C13H17FN2O6, M+Na), 339.0968; found 339.0978. 
 
tert-butyl 3-(1,2-dimethoxyethyl)-5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-
carboxylate (10e) 
Isolated by gradient elution from the column with hexane/EtOAc as eluent (10:1) in 44 % 
yield as a colorless oil. 
1
H NMR (400 MHz, CDCl3): 7.47 (d, J = 5.8 Hz, 1H), 5.69-5.67 (m, 1H), 3.60-3.58 (m, 2H), 
3.42 (s, 3H), 3.40 (s, 3H), 1.62 (s, 9H). 
13
C NMR (101 MHz, CDCl3): 154.7 (d, J = 27 Hz), 147.9, 146.7, 140.3 (d, J = 240 Hz), 
123.7 (d, J = 33.5 Hz), 88.0, 85.4, 72.4, 59.9, 57.6, 27.6. 
HRESI-MS: calculated for (C13H19FN2O6, M+Na), 341.1125; found 341.1120. 
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9.     NMR Spectra 
1H and 13C NMR spectra of N-benzyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3a) 
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1H and 13C NMR spectra of N-cyclohexyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3b) 
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1H and 13C NMR spectra of N-(tert-butyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (3c) 
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1
H and 
13
C NMR of N-(2,2-dimethylpent-4-en-1-yl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (3d) 
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1
H and 
13
C NMR of N-allyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3e) 
 
 
  
S27 
 
 
1H and 13C NMR of N-(1-phenylethyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (d.r. 2:3) major 
isomer (3f)  
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1
H and 
13
C NMR of N-(1-phenylethyl)-N-(tetrahydrofuran-2-yl)methanesulfonamide (d.r. 2:3) minor isomer (3g) 
 
 
  
S29 
 
 
1
H and 
13
C NMR spectra of N-phenyl-N-(tetrahydrofuran-2-yl)methanesulfonamide (3h) 
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1
H and 
13
C NMR spectra of N-hexyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3i) 
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1
H and 
13
C NMR spectra of N-cyclohexyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3j) 
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1
H and 
13
C NMR spectra of N-isopropyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3k) 
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1
H and 
13
C NMR spectra of N-allyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide 8 (3l) 
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1
H and 
13
C NMR spectra of N-(2,2-dimethylpent-4-en-1-yl)-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide 2 (3m) 
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1
H and 
13
C NMR spectra of N-benzyl-4-methyl-N-(tetrahydrofuran-2-yl)benzenesulfonamide (3n) 
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1
H and 
13
C NMR spectra of N-(2,2-dimethylpent-4-en-1-yl)-N-(tetrahydrofuran-2-yl)acetamide (5a) 
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1
H and 
13
C NMR spectra of N-allyl-N-(tetrahydrofuran-2-yl)acetamide (5b) 
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1
H and 
13
C NMR spectra of N-benzyl-N-(tetrahydrofuran-2-yl)acetamide (5c) 
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1
H and 
13
C NMR spectra of N-phenyl-N-(tetrahydrofuran-2-yl)acetamide (5d) 
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1
H and 
13
C NMR spectra of 2,2,2-trifluoro-N-hexyl-N-(tetrahydrofuran-2-yl)acetamide (5e) 
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1
H and 
13
C NMR spectra of N-(tert-butyl)-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5f) 
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1
H and 
13
C NMR spectra of N-allyl-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5g) 
 
 
  
S43 
 
1
H and 
13
C NMR spectra of N-benzyl-2,2,2-trifluoro-N-(tetrahydrofuran-2-yl)acetamide (5h) 
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1
H and 
13
C NMR spectra of ethyl-4-(N-(tetrahydrofuran-2-yl)acetamido)benzoate (5i) 
 
 
  
S45 
 
1
H and 
13
C NMR spectra of N-(4-cyanophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5j) 
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1
H and 
13
C NMR spectra of N-(tetrahydrofuran-2-yl)-N-(4-(trifluoromethyl)phenyl)acetamide (5k) 
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1
H and 
13
C NMR spectra of N-(4-bromophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5l) 
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1
H and 
13
C NMR spectra of N-(4-iodophenyl)-N-(tetrahydrofuran-2-yl)acetamide (5m) 
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1
H and 
13
C NMR spectra of N-(4-methoxyphenyl)-N-(tetrahydrofuran-2-yl)acetamide (5n) 
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1
H and 
13
C NMR spectra of N-(6-methylpyridin-2-yl)-N-(tetrahydrofuran-2-yl)acetamide (5o) 
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1
H and 
13
C NMR spectra of 2-(tetrahydrofuran-2-yl)isoindoline-1,3-dione (5p)  
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1
H NMR spectra of 1-(Tetrahydrofuran-2-yl)-1H-imidazole 7(a) and 1-(Tetrahydrofuran-2-yl)-1H-benzo[d]imidazole (7b) 
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1
H and 
13
C NMR spectra of N-[Tetrahydrofuran-2-yl]-1H-indole (7c) 
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1
H and 
13
C NMR spectra of 9-(tetrahydrofuran-2-yl)-9H-carbazole (7d) 
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1
H and 
13
C NMR spectra of N-benzyl-N-(1,4-dioxan-2-yl)methanesulfonamide (8a) 
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1
H and 
13
C NMR spectra of 2-(1,4-dioxan-2-yl)isoindoline-1,3-dione (8b) 
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1
H and 
13
C NMR spectra of N-benzyl-N-(tetrahydro-2H-pyran-2-yl)methanesulfonamide (8c) 
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1
H and 
13
C NMR spectra of 2-(tetrahydro-2H-pyran-2-yl)isoindoline-1,3-dione (8d) 
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1
H and 
13
C NMR spectra of N-allyl-N-(5-methyltetrahydrofuran-2-yl)methanesulfonamide (8e) 
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1
H and 
13
C NMR spectra of N-benzyl-N-(1,2-dimethoxyethyl)methanesulfonamide (8f) 
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1
H and 
13
C NMR spectra of N-benzyl-N-(1,2-dimethoxyethyl)-2,2,2-trifluoroacetamide (8g) 
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1
H and 
13
C NMR spectra of N-benzyl-2,2,2-trifluoro-N-((2-methoxyethoxy)methyl)acetamide (8g’) 
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1
H and 
13
C NMR spectra of N-allyl-N-(1,2-dimethoxyethyl)methanesulfonamide (8h) 
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1
H and 
13
C NMR spectra of 3-(4-methoxybenzyl)-5-methylpyrimidine-2,4(1H,3H)-dione (9a)
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1
H and 
13
C NMR spectra of 3-(4-methoxybenzyl)-5-methyl-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione (10a) 
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1
H and 
13
C NMR spectra of di-tert-butyl 5-fluoro-2,4-dioxopyrimidine-1,3(2H,4H)-dicarboxylate (9b’)
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1
H and 
13
C NMR spectra of tert-butyl 5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate (9b) 
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1
H and 
13
C NMR spectra of tert-butyl-5-fluoro-2,6-dioxo-3-(tetrahydrofuran-2-yl)-3,6-dihydropyrimidine-1(2H)-carboxylate 
(10b)
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1
H and 
13
C NMR spectra of 5-fluoro-1-(tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
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1
H and 
13
C NMR spectra of tert-butyl 5-fluoro-2,6-dioxo-3-(tetrahydro-2H-pyran-2-yl)-3,6-dihydropyrimidine-1(2H)-carboxylate 
(10c)
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1
H and 
13
C NMR spectra of tert-butyl 3-(1,4-dioxan-2-yl)-5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate (10d) 
 
  
S72 
 
1
H and 
13
C NMR spectra of tert-butyl 3-(1,2-dimethoxyethyl)-5-fluoro-2,6-dioxo-3,6-dihydropyrimidine-1(2H)-carboxylate 
(10e)
 
 
